Journal ArticleOPEN ACCESS

Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study

  • Extra J
  • Antoine E
  • Vincent-Salomon A
  • et al.
The Oncologist (2010) 15(8) 799-809
DOI: 10.1634/theoncologist.2009-0029
109Citations
Citations of this article
80Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The Hermine study observed the use of trastuzumab for metastatic breast cancer (MBC) in routine practice, including patients who received trastuzumab treatment beyond progression (TBP).

Cite

CITATION STYLE

APA

Extra, J.-M., Antoine, E. C., Vincent-Salomon, A., Delozier, T., Kerbrat, P., Bethune-Volters, A., … Namer, M. (2010). Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study. The Oncologist, 15(8), 799–809. https://doi.org/10.1634/theoncologist.2009-0029

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free